Heartflow, Inc. Common Stock
HTFL
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $4.3B
$50.00
▼ -0.85%
P/E
-36.76
Mkt Cap
$4.3B
52-Wk Range
$20.13–$51.78
52-Week Range
$20.13 - $51.78
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 61.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary AI and computational fluid dynamics technology with strong patent portfolio
- FDA-cleared platform with clinical validation demonstrating superior diagnostic accuracy
- Established relationships with major healthcare systems and integrated delivery networks
- First-mover advantage in functional stenosis assessment for non-invasive coronary imaging
Bear Case
1 risk
- High volatility (beta 2.0). Larger-than-normal price swings expected.
Growth
Moderate growth ahead
Expanding adoption among interventional cardiologists and cardiac centers globally
Value
Trading at 0.0x Healthcare IT & Services peers — a discount despite the growth profile.
Momentum
Hot
+70.7% over 3m
Quality
Excellent
High-growth business (53% revenue growth, 80% gross margin). Pre-profit but investing in growth.
Dividend
None
No dividend
Smart-money signal
Who's buying HTFL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 18, 2026
AUG 13, 2026
Reported EPS of -$0.07 vs -$0.13 consensus (+47.6% surprise). Revenue of $64.1M vs $56.6M expected (+13.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+47.6%
Revenue trend · last 8Q
—
—
+39%
+40%
+72%
+58%
+41%
+48%
Q1 24
Q2 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$26.8M
$31.1M
$37.2M
$43.4M
$46.3M
$49.1M
$52.6M
$64.1M
Margins · last 8Q
Gross
83.0%
Operating
-27.9%
Profit
-24.6%
Wall Street consensus
5 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Piper Sandler · Aug 14, 2026
vs Industry
How HTFL stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related